Globus Medical (GMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.086x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($412.11 Million) by net assets ($4.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Globus Medical market capitalisation for the company's overall valuation and market capitalisation.
Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Globus Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency. Explore GMED operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LandMark Optoelectronics
TWO:3081
|
0.057x |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
|
-0.060x |
|
Lineage, Inc. Common Stock
NASDAQ:LINE
|
0.025x |
|
Wynn Resorts Limited
NASDAQ:WYNN
|
-0.543x |
|
Sprott Physical Gold and Silver Trust
TO:CEF
|
-0.001x |
|
Jiangsu Yanghe Brewery Joint-Stock Co Ltd
SHE:002304
|
0.010x |
|
Piraeus Financial Holdings S.A
AT:TPEIR
|
0.109x |
|
Oil India Limited
NSE:OIL
|
0.054x |
Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)
The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. View GMED stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.57 Billion | $753.45 Million | 0.165x | +32.19% |
| 2024-12-31 | $4.18 Billion | $520.64 Million | 0.125x | +104.63% |
| 2023-12-31 | $4.00 Billion | $243.50 Million | 0.061x | -36.99% |
| 2022-12-31 | $1.85 Billion | $178.47 Million | 0.097x | -39.07% |
| 2021-12-31 | $1.74 Billion | $276.27 Million | 0.159x | +20.21% |
| 2020-12-31 | $1.51 Billion | $198.79 Million | 0.132x | +7.63% |
| 2019-12-31 | $1.40 Billion | $171.97 Million | 0.123x | -19.97% |
| 2018-12-31 | $1.19 Billion | $181.64 Million | 0.153x | -7.05% |
| 2017-12-31 | $967.78 Million | $159.53 Million | 0.165x | -20.20% |
| 2016-12-31 | $832.08 Million | $171.89 Million | 0.207x | +21.17% |
| 2015-12-31 | $715.32 Million | $121.96 Million | 0.170x | +26.07% |
| 2014-12-31 | $585.45 Million | $79.17 Million | 0.135x | -31.66% |
| 2013-12-31 | $472.36 Million | $93.47 Million | 0.198x | -0.05% |
| 2012-12-31 | $386.50 Million | $76.52 Million | 0.198x | -26.81% |
| 2011-12-31 | $282.48 Million | $76.41 Million | 0.271x | -13.41% |
| 2010-12-31 | $228.19 Million | $71.29 Million | 0.312x | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more